NEW YORK – A Massachusetts court has declared that 10x Genomics is the exclusive licensee for a key patent family covering droplet technology used in single-cell analysis owned by Harvard University. The ruling raises uncertainty over Harvard's co-exclusive license to 1Cellbio, a codefendant in the case and a 10x competitor that was cofounded by the technology's inventor.